Bryan Hassell

Nirrin asks bioprocess labs to trade chemometric models for a library of known spectra

Nirrin's chief executive says its tunable-laser near-infrared platform reports concentrations directly, so one method built in process development runs unchanged in manufacturing, and five to 10 large drugmakers already use it in development.